Lung Cancer Clinical Trials in Phoenix, AZ

Lung Cancer Clinical Trials in Phoenix, AZ

View the best 10 lung cancer medical studies in Phoenix, Arizona. Access promising new therapies by applying to a Phoenix-based Lung Cancer clinical trial.

Top rated lung cancer clinical trials in Phoenix, Arizona

Here are the top 10 medical studies for lung cancer in Phoenix, Arizona

Image of Alabama Oncology - Grandview in Birmingham, United States.

Sitravatinib +2 More

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of University of Alabama at Birmingham Comprehensive Cancer Center in Birmingham, United States.

NovoTTF-200M device

Device

Recruiting2 awardsPhase 3
This trial tests a device to treat brain metastases in advanced NSCLC patients, comparing it to the current standard of care.
Image of Research Site in Phoenix, United States.

Durvalumab +6 More

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial is testing two different ways to treat lung cancer that has spread, one with two immunotherapy drugs and one with just one immunotherapy drug, compared to just using chemotherapy drugs.
Image of Scottsdale Healthcare Hospitals DBA HonorHealth in Scottsdale, United States.

PF-06940434

Integrin Antagonist

Recruiting1 awardPhase 1
This trial is testing the safety and effectiveness of a new drug, PF-06940434, for treating various types of cancer. The trial has two parts: first, researchers will test different doses of the drug to find the best dose, and then they will test the drug in combination with another drug, anti-PD-1.
Image of Honor Health Research Institute in Scottsdale, United States.

Dabrafenib +1 More

Protein Kinase Inhibitor

Recruiting3 awardsPhase 4
This trial is to provide access for patients who have completed a Novartis or former GSK-sponsored study and are judged by the investigator as benefiting from continued treatment.
Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of Mayo Clinic of Scottsdale in Scottsdale, United States.

LOXO-292

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is designed to study the effects of a new drug, selpercatinib, on various types of solid tumors. The goal is to see if it is safe and tolerable, how it is metabolized, and if it has any preliminary anti-tumor activity.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Ironwood Cancer and Research Center in Chandler, United States.

DS-1062a +1 More

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial will compare the effectiveness of DS-1062a to the current standard of care drug, docetaxel, in treating lung cancer.

Popular filter options for lung-cancer phoenix trials

Phase 3 Clinical Trials

View 61 phase 3 medical studies.

Clinical Trials With No Placebo

View 61 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.